CSHNX
Price
$13.28
Change
+$0.01 (+0.08%)
Updated
Sep 11 closing price
Net Assets
1.28B
VLPIX
Price
$19.47
Change
-$0.05 (-0.26%)
Updated
Sep 11 closing price
Net Assets
53.12M
Interact to see
Advertisement

CSHNX vs VLPIX

CSHNX vs VLPIX Comparison Chart in %
View a ticker or compare two or three
VS
CSHNX vs. VLPIX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSHNX is a Hold and VLPIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CSHNX has more cash in the bank: 1.29B vs. VLPIX (53.1M). CSHNX pays higher dividends than VLPIX: CSHNX (5.44) vs VLPIX (1.78). CSHNX was incepted earlier than VLPIX: CSHNX (12 years) vs VLPIX (11 years). VLPIX (1.47) and CSHNX (1.46) have similar cost to investors . VLPIX is a more actively managed with annual turnover of: 61.00 vs. CSHNX (31.00). CSHNX has a lower initial minimum investment than VLPIX: CSHNX (2500) vs VLPIX (100000). CSHNX annual gain was more profitable for investors over the last year : 24.86 vs. VLPIX (20.27). CSHNX (174.80) and VLPIX (172.09) have equivalent 5 years return.
CSHNXVLPIXCSHNX / VLPIX
Total Expense Ratio1.461.15127%
Annual Report Gross Expense Ratio1.461.4799%
Fund Existence12 years11 years-
Gain YTD31.81826.469120%
Front Load5%N/A-
Min. Initial Investment25001000003%
Min. Initial Investment IRAN/AN/A-
Net Assets1.29B53.1M2,420%
Annual Yield % from dividends5.441.78306%
Returns for 1 year24.8620.27123%
Returns for 3 years90.5178.47115%
Returns for 5 years174.80172.09102%
Returns for 10 years105.04179.6058%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IOLZX34.290.18
+0.53%
ICON Equity Institutional
CSAZX14.31N/A
N/A
Columbia Global Opportunities Inst
GEIZX19.15N/A
N/A
GuideStone Funds Growth Equity Index Inv
JDESX52.52N/A
N/A
JPMorgan US Research Enhanced Equity I
CHCCX13.47N/A
N/A
AB Discovery Growth C